Download PDF
Laryngorhinootologie 2011; 90: S83-S109
DOI: 10.1055/s-0030-1270449
Referat

© Georg Thieme Verlag KG Stuttgart · New York

Funktionserhaltende Therapie des Kehlkopf- und des Hypopharynxkarzinoms

Functional Organ Preservation in Laryngeal and Hypopharyngeal CancerP. Ambrosch1 , A. Fazel2
  • 1Direktorin der Klinik für Hals-, Nasen-, Ohrenheilkunde, Kopf- und Halschirurgie der Christian-Albrechts-Universität zu Kiel
  • 2Oberärztin der Klinik für Hals-, Nasen-, Ohrenheilkunde, Kopf- und Halschirurgie der Christian-Albrechts-Universität zu Kiel
Further Information

Publication History

Publication Date:
26 April 2011 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Prinzipien der transzervikalen und lasermikrochirurgischen Kehlkopfteilresektionen werden beschrieben, die onkologischen und funktionellen Ergebnisse diskutiert und den Ergebnissen der Strahlentherapie respektive der Radiochemotherapie gegenübergestellt. In den letzten 10 Jahren hat die endoskopische Kehlkopfteilresektion bei frühen Stimmlippen- und supraglottischen Kehlkopfkarzinomen breite Anwendung gefunden und die transzervikalen Teilresektionen zurückgedrängt. Die onkologischen Ergebnisse hinsichtlich Überleben und Kehlkopferhalt der verschiedenen Kehlkopfteilresektionen sind vergleichbar, die funktionellen Ergebnisse der endoskopischen Chirurgie sind besser und die Morbidität ist deutlich geringer. Unter dem Aspekt des Kehlkopferhalts, sind die chirurgischen Verfahren der Strahlentherapie überlegen. Es hat sich gezeigt, dass mit der Lasermikrochirurgie bei Stimmlippenkarzinomen mit Bewegungseinschränkung oder Fixation, bei supraglottischen Karzinomen mit Befall des prä- und/oder des paraglottischen Raums sowie bei Hypopharynxkarzinomen bei geeigneter Indikationsstellung mit vertretbarer Morbidität gute onkologische und funktionelle Resultate erzielt worden sind. Bei diesen Tumoren sind transzervikale Teilresektionen bei selektierten Patienten an Zentren mit anerkannter Expertise erfolgreich durchgeführt worden. Die zunächst sehr positiv bewerteten Studienergebnisse über die Effektivität der Radiochemotherapie mit dem Ziel des Organerhalts beim Kehlkopf- und Hypopharynxkarzinom werden in der letzten Zeit aufgrund von Berichten über Spätkomplikationen kritischer gesehen.

Abstract

Functional Organ Preservation in Laryngeal and Hypopharyngeal Cancer

The principles of open vs. laser microsurgical approaches for partial resections of the larynx are described, oncological as well as functional results discussed and corresponding outcomes following primary radiotherapy are opposed. Over the last decade, the endoscopic partial resection of the larynx has developed to an accepted approach in the treatment of early glottic and supraglottic carcinomas thus leading to a remarkable decline in the use of open surgery. Comparing the various surgical approaches of laryngeal partial resections, the oncological outcome of the patients, as far as survival and organ preservation are concerned, are comparable, whereas functional results of the endoscopic procedures are superior with less morbidity. The surgical procedures put together, are all superior to radiotherapy concerning organ preservation. Transoral laser microsurgery has been used successfully for vocal cord carcinomas with impaired mobility or fixation of the vocal cord, supraglottic carcinomas with infiltration of the pre- and/or paraglottic space as well as for selected hypopharyngeal carcinomas. It has been well documented that laser microsurgery achieves good oncological as well as functional results with reasonable morbidity. However, patients with those tumours have been successfully treated by open partial resections of the larynx at medical centres with appropriate expertise. The initially enthusiastic assessment of study results concerning the efficacy of various protocols of chemoradiation with the intent of organ preservation for laryngeal and hypopharyngeal carcinomas are judged more cautious, today, due to recent reports of rather high rates of late toxicity complications.

Schlüsselwörter

Larynxkarzinom - Hypopharynxkarzinom - Behandlung - Organerhalt - Kehlkopfteilresektion - transorale Lasermikrochirurgie - Chemoradiotherapie

Key words

laryngeal cancer - hypopharyngeal cancer - treatment - organ preservation - partial laryngectomy - transoral laser microsurgery - chemoradiation

Literatur

  • 1 Stutsman AC, McGavran MH. Ultraconservative management of superficially invasive epidermoid carcinoma of the true vocal cord.  Ann Otol. 1971;  80 507-512
    PubMedGoogle Scholar
  • 2 Nassif R, Loughran S, Moyes C, MacKenzie K. Negative pathology following endoscopic resection of T1a squamous carcinoma of the glottis.  J Laryngol Otol. 2005;  119 592-594
    PubMedGoogle Scholar
  • 3 Steiner W, Ambrosch P. Endoscopic laser surgery of the upper aerodigestive tract. Stuttgart, New York, Georg Thieme; 2000
    Google Scholar
  • 4 Tillmann B. Atlas der Anatomie. Berlin, Heidelberg, New York, Springer; 2. Auflage 2010
    CrossrefGoogle Scholar
  • 5 Ambrosch P, Steiner W. Komplikationen nach transoraler Lasermikrochirurgie von Mundhöhlen-, Rachen- und Kehlkopfkarzinomen.  Otorhinolaryngologia Nova. 1995;  5 268-274
    PubMedGoogle Scholar
  • 6 Tillman B. Farbatlas der Anatomie. Zahnmedizin – Humanmedizin. Stuttgart, New York, Georg Thieme; 1997
    Google Scholar
  • 7 Ambrosch P, Brinck U, Fischer G, Steiner W. Special features of histopathological diagnosis in laser microsurgery of carcinomas of the upper aerodigestive tract.  Laryngorhinootologie. 1994;  73 78-83
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Manola M, Moscillo L, Costa G, Barillari U, Lo Sito S, Mastella A, Ionna F. Conservative laser microsurgery for T1 glottic carcinoma.  Auris Nasus Larynx. 2008;  35 141-147
    CrossrefPubMedGoogle Scholar
  • 9 Ambrosch P. Lasers for malignant lesions in the upper aerodigestive tract. In: Hüttenbrink KB (ed.). Lasers in Otorhinolaryngology Georg Thieme Verlag, Stuttgart; 2005: 113-141
    Google Scholar
  • 10 Preuss SF, Cramer K, Drebber U, Klussmann JP, Eckel HE, Guntinas-Lichius O. Second-look microlaryngoscopy to detect residual carcinoma in patients after laser surgery for T1 and T2 laryngeal cancer.  Acta Otolaryngol. 2008;  16 1-5
    PubMedGoogle Scholar
  • 11 Sigston E, de Mones E, Babin E, Hans S, Hartl DM, Clement P, Brasnu DF. Early stage glottic cancer. Oncologic results and margins in laser cordectomy.  Arch Otolaryngol Head Neck Surg. 2006;  132 147-152
    CrossrefPubMedGoogle Scholar
  • 12 Crespo AN, Chone CT, Gripp FM, Spina AL, Altemani A. Role of margin status in recurrence after CO2 laser endoscopic resection of early glottic cancer.  Acta Otolaryngol. 2006;  126 306-310
    CrossrefPubMedGoogle Scholar
  • 13 Hartl DM, de Mones E, Hans S, Janot F, Brasnu D. Treatment of early-stage glottic cancer by transoral laser resection.  Ann Otol Rhinol Laryngol. 2007;  116 832-836
    CrossrefPubMedGoogle Scholar
  • 14 Brondbo K, Fridrichs K, Boysen M. Laser surgery for T1 glottic carcinomas: significance of resection margins.  Eur Arch Otorhinolaryngol. 2007;  264 627-630
    CrossrefPubMedGoogle Scholar
  • 15 Remacle M, Lawson G. Results with collagen injection into the vocal folds for medialization.  Curr Opin Otolaryngol Head Neck Surg. 2007;  15 148-152
    CrossrefPubMedGoogle Scholar
  • 16 Thumfart WF, Eckel HE. Endolaryngeale Laserchirurgie zur Behandlung von Kehlkopfkarzinomen.  HNO. 1990;  38 174-178
    PubMedGoogle Scholar
  • 17 Remacle M, Eckel HE, Antonelli A, Brasnu D, Chevalier D, Friedrich G, Olofsson J, Rudert HH, Thumfart WF, de Vincentis M, Wustrow TPU. Endoscopic cordectomy. A proposal for a classification by the working committee, European Laryngological Society.  Eur Arch Otorhinolaryngol. 2000;  257 227-231
    CrossrefPubMedGoogle Scholar
  • 18 Birchall M. EaStER – early stage glottic cancer: endoscopic excision or radiotherapy: a feasibility study.  National Research Register. N0212194189 (2007)
    PubMedGoogle Scholar
  • 19 Coman WB, Hendrkz JK, Hickey B. et al . Laser Surgery for early glottic cancer.  Head Neck Surg ANZ J Surg. 2003;  73 (Suppl. 1) A57
    PubMedGoogle Scholar
  • 20 Thomas JV, Olsen KD, Neel 3rd HB, DeSanto LW, Suman VJ. Early glottic carcinoma treated with open laryngeal procedures.  Arch Otolaryngol Head Neck Surg. 1994;  120 264-268
    CrossrefPubMedGoogle Scholar
  • 21 Spector JG, Sessions DG, Chao KS, Hanson JM, Simpson JR, Perez CA. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery.  Head Neck. 1999;  21 116-123
    CrossrefPubMedGoogle Scholar
  • 22 Spector JG, Sessions DG, Chao KS, Haughey BH, Hanson JM, Simpson JR, Perez CA. Stage I (T1N0M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.  Head Neck. 1999;  21 707-717
    CrossrefPubMedGoogle Scholar
  • 23 Brumund KT, Gutierrez-Fonseca R, Garcia D, Babin E, Hans S, Laccourreye O. Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience.  Ann Otol Rhinol Laryngol. 2005;  114 314-322
    CrossrefPubMedGoogle Scholar
  • 24 Crampette L, Garrel R, Gardiner Q, Maurice N, Mondain M, Makeieff M, Guerrier B. Modified subtotal laryngectomy with cricohyoidoepiglottopexy – long term results in 81 patients.  Head Neck. 1999;  21 95-103
    CrossrefPubMedGoogle Scholar
  • 25 Makeieff M, de la Breteque A, Guerrier B, Giovanni A. Voice handicap evaluation after supracricoid partial laryngectomy.  Laryngoscope. 2009;  119 746-750
    CrossrefPubMedGoogle Scholar
  • 26 Jacobson BH, Jonson A, Grywalski C. The Voice Handicap Index (VHI): development and validation.  Am J Speech Lang Pathol. 1997;  6 66-70
    PubMedGoogle Scholar
  • 27 Steiner W. Results of curative laser microsurgery of laryngeal carcinomas.  Am J Otolaryngol. 1993;  14 116-121
    CrossrefPubMedGoogle Scholar
  • 28 Ambrosch P. The role of laser microsurgery in the treatment of laryngeal cancer.  Curr Opin Otolaryngol Head Neck Surg. 2007;  15 82-88
    CrossrefPubMedGoogle Scholar
  • 29 Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A. Current trends in initial management of laryngeal cancer: the declining use of open surgery.  Eur Arch Otorhinolaryngol. 2009;  266 1333-1352
    CrossrefPubMedGoogle Scholar
  • 30 Ambrosch P, Rödel R, Kron M, Steiner W. Die transorale Lasermikrochirurgie des Larynxkarzinoms. Eine retrospektive Analyse von 657 Patientenverläufen.  Onkologe. 2001;  7 505-512
    CrossrefPubMedGoogle Scholar
  • 31 Mahieu H, Peeters J, Snel F, Leemans R. Transoral endoscopic surgery for early glottic cancer. Proceedings of the Fifth International Conference on Head and Neck Cancer.  San Francisco, July 29-August 2. 2000;  165-172
    PubMedGoogle Scholar
  • 32 Eckel HE. Local recurrences following transoral laser surgery for early glottic carcinoma: frequency, management, and outcome.  Ann Otol Rhinol Laryngol. 2001;  110 7-15
    PubMedGoogle Scholar
  • 33 Gallo A, de Vincentiis M, Manciocco V, Simonelli M, Fiorella ML, Shah JP. CO2 laser cordectomy for early-stage glottic carcinoma: a long-term follow-up of 156 cases.  Laryngoscope. 2002;  112 370-374
    CrossrefPubMedGoogle Scholar
  • 34 Pradhan SA, Pai PS, Neeli SI, D’Cruz AK. Transoral laser surgery for early glottic cancers.  Arch Otolaryngol Head Neck Surg. 2003;  129 623-625
    CrossrefPubMedGoogle Scholar
  • 35 Motta G, Esposito E, Motta S, Tartaro G, Testa D. CO2 laser surgery in the treatment of glottic cancer.  Head Neck. 2005;  27 566-574
    CrossrefPubMedGoogle Scholar
  • 36 Ledda GP, Grover N, Pundir V, Masala E, Puxeddu R. Functional outcomes after CO2 laser treatment of early glottic carcinoma.  Laryngoscope. 2006;  116 1007-1011
    PubMedGoogle Scholar
  • 37 Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC. Transoral laser microsurgery for untreated glottic carcinoma.  Otolaryngol Head Neck Surg. 2007;  137 482-486
    CrossrefPubMedGoogle Scholar
  • 38 Sjögren EV, van Rossum MA, Langeveld TPM, Voerman MS, van de Kamp VAH, Friebel MOW, Wolterbeek R, Baatenburg de Jong RJ. Voice outcome in T1a midcord glottic carcinoma.  Arch Otolaryngol Head Neck Surg. 2008;  134 965-972
    CrossrefPubMedGoogle Scholar
  • 39 Peretti G, Piazza C, Cocco D, De Benedetto L, Del Bon F, Redaelli De Zinis LO, Nicolai P. Transoral CO2 laser treatment for Tis-T3 glottic cancer: the University of Brescia experience on 595 patients.  Head Neck. 2010;  32 977-983
    PubMedGoogle Scholar
  • 40 Eckel HE, Thumfart WF, Jungehülsing M, Sittel C, Stennert E. Transoral laser surgery for early glottic carcinoma.  Eur Arch Otorhinolaryngol. 2000;  257 221-226
    CrossrefPubMedGoogle Scholar
  • 41 Peretti G, Piazza C, Mensi MC, Magnoni L, Bolzoni A. Endoscopic treatment of cT2 glottic carcinoma: prognostic impact of different pT subcategories.  Ann Otol Rhinol Laryngol. 2005;  114 579-586
    PubMedGoogle Scholar
  • 42 Karatzanis AD, Psychogios G, Zenk J, Waldfahrer F, Hornung J, Velegrakis GA, Iro H. Comparison among different available surgical approaches in T1 glottic cancer.  Laryngoscope. 2009;  119 1704-1708
    CrossrefPubMedGoogle Scholar
  • 43 Paulsen F, Tillmann B. Struktur und Funktion des ventralen Stimmlippenansatzes. Unter klinischen Gesichtspunkten.  Laryngorhinootologie. 1996;  75 590-596
    Article in Thieme ConnectPubMedGoogle Scholar
  • 44 Rucci L, Gammarota L, Borghi Cirri MB. Carcinoma of the anterior commissure of the larynx: I. Embryological and anatomic considerations.  Ann Otol Rhinol Laryngol. 1996;  105 303-308
    PubMedGoogle Scholar
  • 45 Rucci L, Gammarota L, Gallo O. Carcinoma of the anterior commissure of the larynx: II. Proposal of a new staging system.  Ann Otol Rhinol Laryngol. 1996;  105 391-396
    PubMedGoogle Scholar
  • 46 Kirchner JA, Carter D. Intralaryngeal barriers to the spread of cancer.  Acta Otolaryngol (Stockh). 1987;  103 503-513
    PubMedGoogle Scholar
  • 47 Kirchner JA. What have whole organ sections contributed to the treatment of laryngeal cancer?.  Ann Otol Rhinol Laryngol. 1989;  98 661-667
    PubMedGoogle Scholar
  • 48 Hartl DM, Landry G, Hans S, Marandas P, Brasnu D. Organ preservation surgery for laryngeal squamous cell carcinoma: low incidence of thyroid cartilage invasion.  Laryngoscope. 2010;  120 1173-1176
    PubMedGoogle Scholar
  • 49 Bradley PJ, Rinaldo A, Suarez C, Shaha AR, Leemans CR, Langendijk JA, Patel SG, Ferlito A. Primary treatment of the anterior vocal commissure squamous carcinoma.  Eur Arch Otorhinolaryngol. 2006;  263 879-888
    CrossrefPubMedGoogle Scholar
  • 50 Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy.  J Clin Oncol. 2001;  19 4029-4036
    PubMedGoogle Scholar
  • 51 Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: The Christie and Royal Marsden Hospital experience.  Radiother Oncol. 2003;  68 105-111
    CrossrefPubMedGoogle Scholar
  • 52 Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time.  Int J Radiat Oncol Biol Phys. 2006;  64 77-82
    CrossrefPubMedGoogle Scholar
  • 53 Sjögren EV, Wiggenraad RGJ, Le Cessie S, Snijder S, Pomp J, Baatenburg de Jong RJ. Outcome of radiotherapy in T1 glottic carcinoma: a population-based study.  Eur Arch Otorhinolaryngol. 2009;  266 735-744
    CrossrefPubMedGoogle Scholar
  • 54 Laccourreye O, Weinstein G, Brasnu D, Trotoux J, Laccourreye H. Vertical partial laryngectomy: a critical analysis of local recurrence.  Ann Otol Rhinol Laryngol. 1991;  100 68-71
    CrossrefPubMedGoogle Scholar
  • 55 Laccourreye O, Muscatello L, Laccourreye L, Naudo P, Brasnu D, Weinstein G. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for “early” glottic carcinoma classified as T1-T2N0 invading the anterior commissure.  Am J Otolaryngol. 1997;  18 385-390
    CrossrefPubMedGoogle Scholar
  • 56 Bron L, Brossard E, Monnier P, Pasche P. Supraglottic partial laryngectomy with cricohyoidoepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas.  Laryngoscope. 2000;  110 627-634
    CrossrefPubMedGoogle Scholar
  • 57 Bron LP, Soldati D, Zouhair A, Ozsahin M, Brossard E, Monnier P, Pasche P. Treatment of early stage squamous-cell carcinoma of the glottic larynx: endoscopic surgery or cricohyoidoepiglottopexy versus radiotherapy.  Head Neck. 2001;  23 823-829
    CrossrefPubMedGoogle Scholar
  • 58 Bron L, Pasche P, Brossard E, Monnier P, Schweizer V. Functional analysis after supracricoid partial laryngectomy with cricohyoidoepiglottopexy.  Laryngoscope. 2002;  112 1289-1293
    CrossrefPubMedGoogle Scholar
  • 59 Steiner W, Ambrosch P, Rödel RM, Kron M. Impact of anterior commissure involvement on local control of early glottic carcinoma treated by laser microresection.  Laryngoscope. 2004;  114 1485-1491
    CrossrefPubMedGoogle Scholar
  • 60 Rödel RM, Steiner W, Müller RM, Kron M, Matthias C. Endoscopic laser surgery of early glottic cancer: involvement of the anterior commissure.  Head Neck. 2009;  31 583-592
    CrossrefPubMedGoogle Scholar
  • 61 Sachse F, Stoll W, Rudack C. Evaluation of treatment results with regard to initial anterior commissure involvement in early glottic carcinoma treated by external partial surgery or transoral laser microresection.  Head Neck. 2009;  31 531-537
    CrossrefPubMedGoogle Scholar
  • 62 Chone CT, Yonehara E, Martins JE, Altemani A, Crespo AN. Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection.  Arch Otolaryngol Head Neck Surg. 2007;  133 882-887
    CrossrefPubMedGoogle Scholar
  • 63 Peretti G, Piazza C, Bolzoni A, Mensi MC, Rossini M, Parinello G, Shapshay SM, Antonelli A. Analysis of recurrences in 322 Tis, T1, or T2 glottic carcinoma: a long-term follow-up of 156 cases.  Laryngoscope. 2004;  113 853-858
    PubMedGoogle Scholar
  • 64 Herranz J, Gavilan J, Vazquez-Barros JC. Carcinoma of the anterior commissure.  Acta Otorrinolaringol Esp. 2007;  58 367-370
    CrossrefPubMedGoogle Scholar
  • 65 Skladowski K, Tarnawski R, Maciejewski B, Wygoda A, Slosarek K. Clinical radiobiology of glottic T1 squamous cell carcinoma.  Int J Radiat Oncol Biol Phys. 1999;  43 101-106
    CrossrefPubMedGoogle Scholar
  • 66 Dinshaw KA, Sharma V, Agarwal JP, Ghosh S, Havaldar R. Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications.  Int J Radiat Oncol Biol Phys. 2000;  48 723-735
    CrossrefPubMedGoogle Scholar
  • 67 Brouha XD, Op De Coul B, Terhaard CH, Hordijk GJ. Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma?.  Clin Otolaryngol Allied Sci. 2000;  25 215-218
    PubMedGoogle Scholar
  • 68 Johansen LV, Grau C, Overgaard J. Glottic carcinoma – patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients.  Radiother Oncol. 2002;  63 257-267
    CrossrefPubMedGoogle Scholar
  • 69 Jorgensen K, Godballe C, Hansen O, Bastholt L. Cancer of the larynx. Treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients.  Acta Oncol. 2002;  41 69-76
    CrossrefPubMedGoogle Scholar
  • 70 Cho EI, Sasaki CT, Haffty BG. Prognostic significance of pre-treatment hemoglobin for local control and overall survival in T1-T2N0 larynx cancer treated with external beam radiotherapy.  Int J Radiat Oncol Biol Phys. 2004;  58 1135-1140
    CrossrefPubMedGoogle Scholar
  • 71 Cellai E, Frata P, Magrini SM, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Bonetti B, Vitali E, De Stefani A, Buglione M, Biti G. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.  Int J Radiat Oncol Biol Phys. 2005;  63 1378-1386
    CrossrefPubMedGoogle Scholar
  • 72 Groome PA, O’Sullivan B, Mackillop WJ, Jackson LD, Schulze K, Irish JC, Warde PR, Schneider KM, Mackenzie RG, Hodson DI, Hammond JA, Gulavita SPP, Eapen LJ, Dixon PF, Bissett RJ. Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules.  Int J Radiat Oncol Biol Phys. 2006;  64 1002-1012
    CrossrefPubMedGoogle Scholar
  • 73 Tamura Y, Tanaka S, Asato R, Hirano S, Yamashita M, Tamaki H, Ito J. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years.  Acta Otolaryngol Suppl. 2007;  557 62-65
    PubMedGoogle Scholar
  • 74 Smee RI, Meagher NS, Williams JR, Broadley K, Bridger GP. Role of radiotherapy in early glottic carcinoma.  Head Neck. 2010;  32 850-859
    PubMedGoogle Scholar
  • 75 Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy.  Int J Radiat Oncol Biol Phys. 2010;  78 461-466
    CrossrefPubMedGoogle Scholar
  • 76 Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR, Ang KK. Results of radiotherapy for T2N0 glottic carcinoma: Does the “2” stand for twice-daily treatment?.  Int J Radiat Oncol Biol Phys. 2003;  55 322-328
    CrossrefPubMedGoogle Scholar
  • 77 Frata P, Cellai E, Magrini SM, Bonetti B, Vitali E, Tonoli S, Buglione M, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Biti G. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease.  Int J Radiat Oncol Biol Phys. 2005;  63 1387-1394
    CrossrefPubMedGoogle Scholar
  • 78 Dagan R, Morris CG, Bennett JA, Mancuso AA, Amdur RJ, Hinerman RW, Mendenhall WM. Prognostic significance of paraglottic space invasion in T2N0 glottic carcinoma.  Am J Clin Oncol. 2007;  30 186-190
    CrossrefPubMedGoogle Scholar
  • 79 Thurnher D, Erovic BM, Frommlet F, Brannath W, Ehrenberger K, Jansen B, Selzer E, Grasl MC. Challenging a dogma – Surgery yields superior long-term results for T1a squamous cell carcinoma of the glottic larynx compared to radiotherapy.  EJSO. 2008;  34 692-698
    PubMedGoogle Scholar
  • 80 Keilmann A, Bergler W, Artzt M, Hörmann K. Vocal function following laser and conventional surgery of small malignant vocal fold tumors.  J Laryngol Otol. 1996;  110 1138-1141
    PubMedGoogle Scholar
  • 81 Tamura E, Kitahara S, Ogura M, Kohno N. Voice quality after laser surgery or radiotherapy for T1a glottic carcinoma.  Laryngoscope. 2003;  113 910-914
    CrossrefPubMedGoogle Scholar
  • 82 Wedman J, Heimdal JH, Elstad I, Olofsson J. Voice results in patients with T1a glottic cancer treated by radiotherapy or endoscopic measures.  Eur Arch Otorhinolaryngol. 2002;  259 547-550
    PubMedGoogle Scholar
  • 83 Verdonck-De Leeuw IM, Keus RB, Hilgers FJM, Koopmans-van Beinum FJ, Greven AJ, Jong de JMA, Vreeburg G, Bartelink H. Consequences of voice impairment in daily life for patients following radiotherapy for early glottic cancer: voice quality, vocal function, and vocal performance.  Int J Rad Oncol Biol Phys. 1999;  44 1071-1078
    CrossrefPubMedGoogle Scholar
  • 84 Krengli M, Policarpo M, Manfredda I, Aluffi P, Gambaro G, Panella M, Pia F. Voice quality after treatment for T1a glottic carcinoma – radiotherapy versus laser cordectomy.  Acta Oncol. 2004;  43 284-289
    CrossrefPubMedGoogle Scholar
  • 85 Nunez-Batalla F, Caminero Cueva MJ, Senaris-Gonzalez B, Llorente-Pendas JL, Gorriz-Gil C, Lopez llames A, Alonso Pantiga R, Suarez-Nieto C. Voice quality after endoscopic laser surgery and radiotherapy for early glottic cancer: objective measurements emphasizing the Voice Handicap Index.  Eur Arch Otorrhinolaryngol. 2008;  265 543-548
    PubMedGoogle Scholar
  • 86 Loughran S, Calder N, MacGregor FB, Carding P, MacKenzie K. Quality of life and voice following endoscopic resection or radiotherapy for early glottic cancer.  Clin Otolaryngol. 2005;  30 42-47
    CrossrefPubMedGoogle Scholar
  • 87 Cohen SM, Garrett CG, Dupont WD, Ossoff RH, Courey MS. Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision.  Ann Otol Rhinol Laryngol. 2006;  115 581-586
    CrossrefPubMedGoogle Scholar
  • 88 Roh JL, Kim DH, Kim SY, Park C. Quality of life and voice in patients after laser cordectomy for Tis and T1 glottic carcinomas.  Head Neck. 2007;  29 1010-1016
    CrossrefPubMedGoogle Scholar
  • 89 Vilaseca I, Huerta P, Blanch JL, Fernandez-Planas AM, Jimenez C, Bernal-Sprekelsen M. Voice quality after CO2 laser cordectomy – what can we really expect?.  Head Neck. 2008;  30 43-49
    CrossrefPubMedGoogle Scholar
  • 90 Kruse E. The role of the phoniatrician in laser surgery of the larynx. In: Steiner W, Ambrosch P: Endoscopic laser surgery of the upper aerodigestive tract. Stuttgart, New York, Georg Thieme; 2000: 124-129
    Google Scholar
  • 91 Benninger MS, Alessi D, Archer S, Bastian R, Ford C, Koufman J, Sataloff RT, Spiegel JR, Woo P. Vocal fold scarring: current concepts and management.  Otolaryngol Head Neck Surg. 1996;  115 474-482
    CrossrefPubMedGoogle Scholar
  • 92 Remacle M, Lawson G, Keghian J, Jamart J. Use of injectable autologous collagen for correcting glottic gaps: initial results.  J Voice. 1999;  13 280-288
    CrossrefPubMedGoogle Scholar
  • 93 Neuenschwander MC, Sataloff RT, Abaza MM, Hawkshaw MJ, Reiter D, Spiegel JR. Management of vocal fold scar with autologous fat implantation: perceptual results.  J Voice. 2001;  15 295-304
    CrossrefPubMedGoogle Scholar
  • 94 Hirano S. Current treatment of vocal fold scarring.  Curr Opin Otolaryngol Head Neck Surg. 2005;  13 143-147
    CrossrefPubMedGoogle Scholar
  • 95 Remacle M, Lawson G, Jamart J, Minet M, Watelet JB, Delos M. CO2 laser in the diagnosis and treatment of early cancer of the vocal fold.  Eur Arch Otorhinolaryngol. 1997;  254 169-176
    CrossrefPubMedGoogle Scholar
  • 96 Arens C, Remacle M. Scarred larynx. In: Remacle M, Eckel HE (eds.). Surgery of larynx and trachea Springer, Heidelberg, Dordrecht, London, New York; 2010: 171-176
    Google Scholar
  • 97 Piazza C, Bolzoni Villaret A, Redaelli De Zinis LO, Cattaneo A, Cocco D, Peretti G. Phonosurgery after endoscopic cordectomies. II. Delayed medialization techniques for major glottic incompetence after total and extended resections.  Eur Arch Otorhinolaryngol. 2007;  264 1185-1190
    CrossrefPubMedGoogle Scholar
  • 98 Sittel C, Friedrich G, Zorowka P, Eckel HE. Surgical voice rehabilitation after laser surgery for glottic carcinoma.  Ann Otol Rhinol Laryngol. 2002;  111 493-499
    PubMedGoogle Scholar
  • 99 Rahbar R, Valdez TA, Shapshay SM. Preliminary results of intraoperative mitomycin-C in the treatment and prevention of glottic and subglottic stenosis.  J Voice. 2000;  14 282-286
    CrossrefPubMedGoogle Scholar
  • 100 Rahbar R, Shapshay SM, Healy GB. Mitomycin: effects on laryngeal and tracheal stenosis, benefits, and complications.  Ann Otol Rhinol Laryngol. 2001;  110 1-6
    PubMedGoogle Scholar
  • 101 Lichtenberger G, Toohill RJ. New keel fixing technique for endoscopic repair of anterior commissure webs.  Laryngoscope. 1994;  104 771-774
    PubMedGoogle Scholar
  • 102 Brandenburg JH. Laser cordotomy versus radiotherapy: an objective cost analysis.  Ann Otol Rhinol Laryngol. 2001;  110 312-317
    PubMedGoogle Scholar
  • 103 Smith JC, Johnson JT, Cognetti DM, Landsittel DP, Gooding WE, Cano ER, Myers EN. Quality of life, functional outcome, and costs of early glottic cancer.  Laryngoscope. 2003;  113 68-76
    CrossrefPubMedGoogle Scholar
  • 104 Goor KM, Peeters AJ, Mahieu HF, Langendijk JA, Leemans CR, Verdonck-de Leeuw IM, van Agthoven M. Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas:costs, local control, survival, quality of life, and voice quality.  Head Neck. 2007;  132 857-861
    PubMedGoogle Scholar
  • 105 Yousem DM, Tufano RP. Laryngeal imaging.  Neuroimaging Clin N Am. 2004;  14 611-624
    CrossrefPubMedGoogle Scholar
  • 106 Motta G, Esposito E, Cassiano B, Motta S. T1-T2-T3 glottic tumors: fifteen years experience with CO2 laser.  Acta Otolaryngol (Stockh). 1997;  527 (Suppl) 155-159
    PubMedGoogle Scholar
  • 107 Hinni ML, Salassa JR, Grant DG, Pearson BW, Hayden RE, Martin A, Christiansen H, Haughey BH, Nussenbaum B, Steiner W. Transoral laser microsurgery for advanced laryngeal cancer.  Arch Otolaryngol Head Neck Surg. 2007;  133 1198-1204
    CrossrefPubMedGoogle Scholar
  • 108 Vilaseca I, Bernal-Sprekelsen M, Luis Blanch J. Transoral laser microsurgery for T3 laryngeal tumors: prognostic factors.  Head Neck. 2010;  32 929-938
    PubMedGoogle Scholar
  • 109 Som ML. Cordal cancer with extension to vocal process.  Laryngoscope. 1975;  85 1298-1307
    CrossrefPubMedGoogle Scholar
  • 110 Piquet JJ, Desaulty A, Pilliaert JM, Decroix G. Results of surgical treatment of cancers of the endolarynx.  Acta Otorhinolaryngol Belg. 1973;  27 916-923
    PubMedGoogle Scholar
  • 111 Lesinski SG, Bauer WC, Ogura FH. Hemilaryngectomy for T3 (fixed cord) epidermoid carcinoma of the larynx.  Laryngoscope. 1976;  86 1563-1571
    CrossrefPubMedGoogle Scholar
  • 112 Biller HF, Lawson W. Partial laryngectomy for vocal cord cancer with marked limitation or fixation of the vocal cord.  Laryngoscope. 1986;  96 61-64
    PubMedGoogle Scholar
  • 113 Vega SF, Scola B, Vega MF, Martinez T, Scola E. Laryngeal vertical partial surgery. Surgical techniques. Oncological and functional results.  Acta Otorhinolaryngol Ital. 1996;  16 272-280
    PubMedGoogle Scholar
  • 114 Razack MS, Maipang T, Sako K, Bakamjian V, Shedd DP. Management of advanced glottic cancer.  Am J Surg. 1989;  159 318-320
    PubMedGoogle Scholar
  • 115 Foote RL, Olsen KD, Buskirk SJ, Stanley RJ, Suman VJ. Laryngectomy alone for T3 glottic cancer.  Head Neck. 1994;  16 406-412
    CrossrefPubMedGoogle Scholar
  • 116 Bryant GP, Poulsen MG, Tripcony L, Dickie GJ. Treatment decisions in T3N0M0 glottic carcinoma.  Int J Radiat Oncol Biol Phys. 1995;  31 285-293
    CrossrefPubMedGoogle Scholar
  • 117 Piquet JJ, Chevalier D. Subtotal laryngectomy with crico-hyoido-epiglotto-pexy for the treatment of extended glottic carcinoma.  Am J Surg. 1991;  162 357-361
    CrossrefPubMedGoogle Scholar
  • 118 Chevalier D, Laccourreye O, Brasnu D, Laccourreye H, Piquet JJ. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients.  Ann Otol Rhinol Laryngol. 1997;  106 364-369
    PubMedGoogle Scholar
  • 119 Laccourreye O, Salzer SJ, Brasnu D, Shen W, Laccourreye H, Weinstein GS. Glottic carcinoma with a fixed true vocal cord: Outcomes after neoadjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidoepiglottopexy.  Otolaryngol Head Neck Surg. 1996;  114 400-406
    CrossrefPubMedGoogle Scholar
  • 120 Laccourreye O, Brasnu D, Biacabe B, Hans S, Seckin S, Weinstein G. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results.  Head Neck. 1998;  20 595-599
    CrossrefPubMedGoogle Scholar
  • 121 Laccourreye O, Diaz EM, Muscatello L, Garcia D, Brasnu D. A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis.  Cancer. 1999;  85 40-46
    CrossrefPubMedGoogle Scholar
  • 122 Laccourreye O, Laccourreye L, Muscatello L, Périé S, Weinstein G, Brasnu D. Local failure after supracricoid partial laryngectomy: symptoms, management, and outcome.  Laryngoscope. 1998;  108 339-344
    CrossrefPubMedGoogle Scholar
  • 123 Dufour X, Hans S, De Mones E, Brasnu D, Menard M, Laccourreye O. Local control after supracricoid partial laryngectomy for advanced endolaryngeal squamous cell carcinoma classified as T3.  Arch Otolaryngol Head Neck Surg. 2004;  130 1092-1099
    CrossrefPubMedGoogle Scholar
  • 124 Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. T1-T2 vocal cord carcinoma: a basis for comparing the results of radiotherapy and surgery.  Head Neck Surg. 1988;  10 373-377
    CrossrefPubMedGoogle Scholar
  • 125 Turesson I, Sandberg N, Mercke C, Johansson KA, Sandin I, Wallgren A. Primary radiotherapy for glottic laryngeal carcinoma stage I and II. A retrospective study with special regard to failure patterns.  Acta Oncol. 1991;  30 357-362
    CrossrefPubMedGoogle Scholar
  • 126 Fein DA, Mendenhall WM, Parsons JT, Million RR. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.  Int J Radiat Oncol Biol Phys. 1993;  25 605-611
    CrossrefPubMedGoogle Scholar
  • 127 Burke LS, Greven KM, McGuirt WT, Case D, Hoen HM, Raben M. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment.  Int J Radiat Oncol Biol Phys. 1997;  38 1001-1006
    CrossrefPubMedGoogle Scholar
  • 128 Marshak G, Brenner B, Shvero J, Shapira J, Ophir D, Hochman I, Marshak G, Sulkes A, Rakowsky E. Prognostic factors for local control of early glottic cancer: the Rabin medical center retrospective study on 207 patients.  Int J Radiat Oncol Biol Phys. 1999;  43 1009-1013
    CrossrefPubMedGoogle Scholar
  • 129 Barthel SW, Esclamado RM. Primary radiation therapy for early glottic cancer.  Otolaryngol Head Neck Surg. 2001;  124 35-39
    CrossrefPubMedGoogle Scholar
  • 130 Parsons JT, Mendenhall WM, Mancuso AA, Cassisi NJ, Stringer SP, Million RR. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx.  Head Neck. 1989;  11 123-128
    CrossrefPubMedGoogle Scholar
  • 131 Mendenhall WM, Parsons JT, Mancuso AA, Pameijer FJ, Stringer SP, Cassissi NJ. Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx.  J Clin Oncol. 1997;  15 2394-2402
    PubMedGoogle Scholar
  • 132 Wylie JP, Sen M, Swindell R, Sykes AJ, Farrington WT, Slevin NJ. Definitive radiotherapy for 114 cases of T3N0 glottic carcinoma: influence of dose-volume parameters on outcome.  Radiotherapy and Oncology. 1999;  53 15-21
    CrossrefPubMedGoogle Scholar
  • 133 Wolf GT, Hong WK, Gross Fisher S. et al . Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.  N Engl J Med. 1991;  324 1685-1690
    CrossrefPubMedGoogle Scholar
  • 134 Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.  N Engl J Med. 2003;  349 2091-2098
    CrossrefPubMedGoogle Scholar
  • 135 Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, Stromboni-Luboinski M, Hill C. Randomized trial of induction chemotherapy in larynx carcinoma.  Oral Oncol. 1998;  34 224-228
    CrossrefPubMedGoogle Scholar
  • 136 Janot F, Rhein B, Koka VN, Wibault P, Domenge C, Bessede JP, Marandas P, Schwaab G, Luboinski B. Laryngeal preservation with induction chemotherapy. Experience of two GETTEC Centers, between 1985 and 1995.  Ann Otolaryngol Chir Cervicofac. 2002;  119 12-20
    PubMedGoogle Scholar
  • 137 Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A, Robinson RA. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.  Laryngoscope. 2006;  116 (S 111) 1-13
    PubMedGoogle Scholar
  • 138 Chen AY, Halpern M. Factors predictive of survival in advanced laryngeal cancer.  Arch Otolaryngol Head Neck Surg. 2007;  133 1270-1276
    CrossrefPubMedGoogle Scholar
  • 139 Lambert L, Fortin B, Soulieres D, Guertin L, Coulombe G, Charpentier D, Tabet JC, Bélair M, Khaouam N, Nguyen-Tan PF. Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding?.  Int J Radiat Oncol Biol Phys. 2010;  76 398-402
    CrossrefPubMedGoogle Scholar
  • 140 Olsen KD. Reexamining the treatment of advanced laryngeal cancer.  Editorial. Head Neck. 2010;  32 1-7
    PubMedGoogle Scholar
  • 141 Alonso JM. Conservative surgery of cancer of the larynx.  Trans Am Acad Ophthalmol Otolaryngol. 1947;  51 633-645
    PubMedGoogle Scholar
  • 142 Labayle J, Dahan S. Reconstructive laryngectomy.  Ann Otolaryngol Chir Cervicofac. 1981;  98 587-592
    PubMedGoogle Scholar
  • 143 Vaughan CW. Transoral laryngeal surgery using the CO2 laser. Laboratory experiments and clinical experience.  Laryngoscope. 1978;  88 1399-1420
    PubMedGoogle Scholar
  • 144 Steiner W, Jaumann MP, Pesch HJ. Endoskopische Therapie von Krebsfrühstadien im Larynx – vorläufige Ergebnisse.  Arch Otorhinolaryngol. 1981;  231 637-643
    CrossrefPubMedGoogle Scholar
  • 145 Steiner W. Experience in endoscopic laser surgery of malignant tumours of the upper aerodigestive tract.  Adv Otorhinolaryngol. 1988;  39 135-144
    PubMedGoogle Scholar
  • 146 Davis RK, Shapshay SM, Strong MS, Hyams VJ. Transoral partial supraglottic resection using the CO2 laser.  Laryngoscope. 1983;  93 429-432
    PubMedGoogle Scholar
  • 147 Davis RK, Kelly SM, Hayes J. Endoscopic CO2 laser excisional biopsy of early supraglottic cancer.  Laryngoscope. 1991;  101 680-683
    PubMedGoogle Scholar
  • 148 Zeitels SM, Vaughan CW, Domanowski GF. Endoscopic management of early supraglottic cancer.  Ann Otol Rhinol Laryngol. 1990;  99 951-956
    PubMedGoogle Scholar
  • 149 Prades JM, Simon PG, Timoshenko AP, Dumollard JM, Schmitt T, Martin C. Extended and standard supraglottic laryngectomies: a review of 110 patients.  Eur Arch Otorhinolaryngol. 2005;  262 947-952
    CrossrefPubMedGoogle Scholar
  • 150 Iro H, Waldfahrer F, Altendorf-Hofmann A, Weidenbecher M, Sauer R, Steiner W. Transoral laser surgery of supraglottic cancer.  Arch Otolaryngol Head Neck Surg. 1998;  124 1245-1250
    CrossrefPubMedGoogle Scholar
  • 151 Blanch JL, Vilaseca I, Bernal-Sprekelsen M, Grau JJ, Moragas M, Traserra-Coderch J, Caballero M, Sabater F, Guilemany JM, Alos L. Prognostic significance of surgical margins in transoral CO2 laser microsurgery for T1-T4 pharyngo-laryngeal cancers.  Eur Arch Otorhinolaryngol. 2007;  264 1045-1051
    CrossrefPubMedGoogle Scholar
  • 152 Jäckel MC, Ambrosch P, Martin A, Steiner W. Impact of re-resection for inadequate margins on the prognosis of upper aerodigestive tract cancer treated by laser microsurgery.  Laryngoscope. 2007;  117 350-357
    CrossrefPubMedGoogle Scholar
  • 153 Remacle M, Hantzakos A, Eckel H, Evrard AS, Bradley PJ, Chevalier D, Djukic V, de Vincentiis M, Friedrich G, Olofsson J, Peretti S, Quer M, Werner J. Endoscopic supraglottic laryngectomy: a proposal for a classification by the working committee on nomenclature, European Laryngological Society.  Eur Arch Otorhinolaryngol. 2009;  266 993-998
    CrossrefPubMedGoogle Scholar
  • 154 Hirano M, Tateishi M, Kurita S, Matsuoka H. Deglutition following supraglottic horizontal laryngectomy.  Ann Otol Rhinol Laryngol. 1987;  96 7-11
    PubMedGoogle Scholar
  • 155 Ambrosch P, Kron M, Steiner W. Carbon dioxide laser microsurgery for early supraglottic carcinoma.  Ann Otol Rhinol Laryngol. 1998;  107 680-688
    CrossrefPubMedGoogle Scholar
  • 156 Rudert HH, Werner JA, Höft S. Transoral carbon dioxide laser resection of supraglottic carcinoma.  Ann Otol Rhinol Laryngol. 1999;  108 819-827
    PubMedGoogle Scholar
  • 157 Cabanillas R, Rodrigo JP, Llorente JL, Suarez V, Ortega P, Suarez C. Functional outcomes of transoral surgery of supraglottic carcinoma compared with a transcervical approach.  Head Neck. 2004;  26 653-659
    CrossrefPubMedGoogle Scholar
  • 158 Peretti G, Piazza C, Cattaneo A, De Benedetto L, Martin E, Nicolai P. Comparison of functional outcomes after endoscopic versus open-neck supraglottic laryngectomies.  Ann Otol Rhinol Laryngol. 2006;  115 827-832
    Google Scholar
  • 159 Kremer B, Schlöndorff G. Late lethal secondary hemorrhage after laser supraglottic laryngectomy.  Arch Otolaryngol Head Neck Surg. 2001;  127 203-205
    PubMedGoogle Scholar
  • 160 Serafini I. Results of supraglottic horizontal laryngectomy. In: Wigand ME, Steiner W, Stell PM, eds.Functional Partial Laryngectomy Berlin, Heidelberg, New York: Springer; 1984: 223-225
    CrossrefGoogle Scholar
  • 161 Vega MF. Early and late complications after partial resections of the larynx. In: Wigand ME, Steiner W, Stell PM, eds.Functional Partial Laryngectomy Berlin, Heidelberg, New York: Springer; 1984: 295-298
    Google Scholar
  • 162 Naudo P, Laccourreye O, Weinstein G, Hans S, Laccourreye H, Brasnu D. Functional outcome and prognostic factors after supracricoid partial laryngectomy with cricohyoidopexy.  Ann Otol Rhinol Laryngol. 1997;  106 291-296
    PubMedGoogle Scholar
  • 163 Schwaab G, Kolb F, Julieron M, Janot F, Le Ridant AM, Mamelle G, Marandas P, Koka VN, Luboinski B. Subtotal laryngectomy with cricohyoidopexy as first treatment procedure for supraglottic carcinoma: Institut Gustave-Roussy experience (146 cases, 1974-1997).  Eur Arch Otorhinolaryngol. 2001;  258 246-249
    CrossrefPubMedGoogle Scholar
  • 164 Joo YH, Sun DI, Cho JH, Kim MS. Factors that predict postoperative pulmonary complications after supracricoid partial laryngectomy.  Arch Otolaryngol Head Neck Surg. 2009;  135 1154-1157
    CrossrefPubMedGoogle Scholar
  • 165 Decotte A, Woisard V, Percodani J, Pessey JJ, Serrano E, Vergez S. Respiratory complications after supracricoid partial laryngectomy.  Eur Arch Otorhinolaryngol. 2010;  267 1415-1421
    CrossrefPubMedGoogle Scholar
  • 166 Nakfoor BM, Spiro IJ, Wang CC, Martins P, Montgomery W, Fabian R. Results of accelerated radiotherapy for supraglottic carcinoma: a Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary experience.  Head Neck. 1998;  20 379-384
    CrossrefPubMedGoogle Scholar
  • 167 Sykes AJ, Slevin NJ, Gupta NK, Brewster AE. 331 cases of clinically node-negative supraglottic carcinoma of the larynx: a study of a modest size fixed field radiotherapy approach.  Int J Radiat Oncol Biol Phys. 2000;  46 1109-1115
    CrossrefPubMedGoogle Scholar
  • 168 Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Robbins KT. Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection.  Head Neck. 2002;  24 456-467
    CrossrefPubMedGoogle Scholar
  • 169 Steininger JR, Parnes SM, Gardner GM. Morbidity of combined therapy for the treatment of supraglottic carcinoma: supraglottic laryngectomy and radiotherapy.  Ann Otol Rhinol Laryngol. 1997;  106 151-158
    PubMedGoogle Scholar
  • 170 Suarez C, Rodrigo JP, Herranz J, Diaz C, Fernandez JA. Complications of supraglottic laryngectomy for carcinomas of the supraglottis and the base of the tongue.  Clin Otolaryngol. 1996;  21 87-90
    CrossrefPubMedGoogle Scholar
  • 171 Spriano G, Antognoni P, Sanguineti G, Sormani M, Richetti A, Ameli F, Piantanida R, Luraghi R, Magli A, Corvo R, Tordiglione M, Vitale V. Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy.  Am J Otolaryngol. 2000;  21 14-21
    CrossrefPubMedGoogle Scholar
  • 172 Laccourreye O, Hans S, Borzog-Grayeli A, Maulard-Durdux C, Brasnu D, Housset M. Complications of postoperative radiation therapy after partial laryngectomy in supraglottic cancer: a long-term evaluation.  Otolaryngol Head Neck Surg. 2000;  122 752-757
    CrossrefPubMedGoogle Scholar
  • 173 Bocca E, Pignataro O, Oldini C. Supraglottic laryngectomy: 30 years of experience.  Ann Otol Rhinol Laryngol. 1983;  92 14-18
    CrossrefPubMedGoogle Scholar
  • 174 Robbins KT, Davidson W, Peters LJ, Goepfert H. Conservation surgery for T2 and T3 carcinomas of the supraglottic larynx.  Arch Otolaryngol Head Neck Surg. 1988;  114 421-426
    CrossrefPubMedGoogle Scholar
  • 175 Soo KC, Shah JP, Gopinath KS, Gerold FP, Jaques DP, Strong EW. Analysis of prognostic variables and results after supraglottic partial laryngectomy.  Am J Surg. 1988;  156 301-305
    CrossrefPubMedGoogle Scholar
  • 176 DeSanto LW. Early supraglottic cancer.  Ann Otol Rhinol Laryngol. 1990;  99 593-597
    PubMedGoogle Scholar
  • 177 Lutz CK, Johnson JT, Wagner RL, Myers EN. Supraglottic carcinoma: patterns of recurrence.  Ann Otol Rhinol Laryngol. 1990;  99 12-17
    PubMedGoogle Scholar
  • 178 Bocca E. Surgical management of supraglottic cancer and its lymph node metastases in a conservative perspective.  Ann Otol Rhinol Laryngol. 1991;  100 261-267
    PubMedGoogle Scholar
  • 179 Suarez C, Rodrigo JP, Herranz J, Llorente JL, Martinez JA. Supraglottic laryngectomy with or without postoperative radiotherapy in supraglottic carcinomas.  Ann Otol Rhinol Laryngol. 1995;  104 358-363
    PubMedGoogle Scholar
  • 180 Herranz-Gonzales J, Gavilan J, Martinez-Vidal J, Gavilan C. Supraglottic laryngectomy: functional and oncologic results.  Ann Otol Rhinol Laryngol. 1996;  105 18-22
    PubMedGoogle Scholar
  • 181 Martinez T, Escamilla Y, Gutierrez M, Bodoque M, Scola B, Vega MF. La cirugia parcial en el carcinoma supraglotico. Resultados oncologicos y functionales.  Acta Otorrinolaringol Esp. 1996;  47 125-128
    PubMedGoogle Scholar
  • 182 Myers EN, Alvi A. Management of carcinoma of the supraglottic larynx: evolution, current concepts, and future trends.  Laryngoscope. 1996;  106 559-567
    CrossrefPubMedGoogle Scholar
  • 183 Maurizi M, Paludetti G, Galli J, Ottaviani F, D’Abramo G, Almadori G. Oncological and functional outcome of conservative surgery for primary supraglottic cancer.  Eur Arch Otorhinolaryngol. 1999;  256 283-290
    CrossrefPubMedGoogle Scholar
  • 184 Bron LP, Soldati D, Monod ML, Megevand C, Brossard E, Monnier P, Pasche P. Horizontal partial laryngectomy for supraglottic squamous cell carcinoma.  Eur Arch Otorhinolaryngol. 2005;  262 302-306
    CrossrefPubMedGoogle Scholar
  • 185 Sevilla MA, Rodrigo JP, Llorente JL, Cabanillas R, Lopez F, Suarez C. Supraglottic laryngectomy: analysis of 267 cases.  Eur Arch Otorhinolaryngol. 2008;  265 11-16
    PubMedGoogle Scholar
  • 186 Isaacs JH, Slattery III WH, Mendenhall WM, Cassisi NJ. Supraglottic laryngectomy.  Am J Otolaryngol. 1998;  19 118-123
    CrossrefPubMedGoogle Scholar
  • 187 Scola B, Fernandez-Vega M, Martinez T, Fernandez-Vega S, Ramirez C. Management of cancer of the supraglottis.  Otorhinolaryngol Head Neck Surg. 2001;  124 195-198
    PubMedGoogle Scholar
  • 188 Herranz J, Martinez-Vidal J, Martinez Moran A. Supraglottic laryngectomy. Still on-going.  Acta Otorrinolaryngol Esp. 2006;  57 235-241
    PubMedGoogle Scholar
  • 189 Laccourreye O, Brasnu D, Merite-Drancy A, Cauchois R, Chabardes E, Menard M, Laccourey H. Cricohyoidopexy in selected infrahyoid epiglottic carcinomas presenting with pathological preepiglottic space invasion.  Arch Otolaryngol Head Neck Surg. 1993;  119 881-886
    CrossrefPubMedGoogle Scholar
  • 190 Chevalier D, Piquet JJ. Subtotal laryngectomy with cricohyoidopexy for supraglottic carcinoma: review of 61 cases.  Am J Surg. 1994;  168 472-473
    CrossrefPubMedGoogle Scholar
  • 191 De Vincentiis M, Minni A, Gallo A, Di Nardo A. Supracricoid partial laryngectomies: oncologic and functional results.  Head Neck. 1998;  20 504-509
    CrossrefPubMedGoogle Scholar
  • 192 Eckel HE, Thumfart WF. Laser surgery for the treatment of larynx carcinomas: indications, techniques, and preliminary results.  Ann Otol Rhinol Laryngol. 1992;  101 113-118
    CrossrefPubMedGoogle Scholar
  • 193 Zeitels SM, Koufman JA, Davis RK, Vaughan CW. Endoscopic treatment of supraglottic and hypopharynx cancer.  Laryngoscope. 1994;  104 71-78
    PubMedGoogle Scholar
  • 194 Eckel HE. Endoscopic laser resection of supraglottic carcinoma.  Otolaryngol Head Neck Surg. 1997;  117 681-687
    CrossrefPubMedGoogle Scholar
  • 195 Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC. Transoral laser microsurgery for carcinoma of the supraglottic larynx.  Otolaryngol Head Neck Surg. 2007;  136 900-906
    CrossrefPubMedGoogle Scholar
  • 196 Agrawal A, Moon J, Davis RK, Sakr WA, Giri SPG, Valentino J, LeBlanc M, Truelson JM, Yoo GH, Ensley JF, Schuller DE. Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx.  Arch Otolaryngol Head Neck Surg. 2007;  133 1044-1050
    CrossrefPubMedGoogle Scholar
  • 197 Bumber Z, Prgomet D, Janjanin S. Endoscopic CO2 laser surgery for supraglottic cancer – ten years of experience.  Coll Antropol. 2009;  33 87-91
    PubMedGoogle Scholar
  • 198 Bussu F, Almadori G, De Corso E, Rizzo D, Rigante M, Parrilla C, Valentini V, Paludetti G. Endoscopic horizontal partial laryngectomy by CO2 laser in the management of supraglottic squamous cell carcinoma.  Head Neck. 2009;  31 1196-1206
    CrossrefPubMedGoogle Scholar
  • 199 Karatzanis AD, Psychogios G, Zenk J, Waldfahrer F, Hornung J, Velegrakis GA, Iro H. Evaluation of available surgical management options for early supraglottic cancer.  Head Neck. 2010;  32 1048-1055
    PubMedGoogle Scholar
  • 200 Motta G, Esposito E, Testa D, Iovine R, Motta S. CO2 laser treatment of supraglottic cancer.  Head Neck. 2004;  26 442-446
    CrossrefPubMedGoogle Scholar
  • 201 Peretti G, Piazza C, Ansarin M, De Benedetto L, Cocco D, Cattaneo A, Nicolai P, Chiesa F. Transoral CO2 laser microsurgery for Tis-T3 supraglottic squamous cell carcinomas.  Eur Arch Otorhinolaryngol. 2010;  267 1735-1742
    CrossrefPubMedGoogle Scholar
  • 202 Harwood AR, Beale FA, Cummings BJ, Keane TJ, Payne DG, Rider WD. Management of early supraglottic laryngeal carcinoma by irradiation with surgery in reserve.  Arch Otolaryngol. 1983;  109 583-585
    CrossrefPubMedGoogle Scholar
  • 203 Spaulding CS, Krochak RJ, Hahn SS, Constable WC. Radiotherapeutic management of cancer of the supraglottis.  Cancer. 1986;  57 1292-1298
    CrossrefPubMedGoogle Scholar
  • 204 Shimm DS, Coulthard SW. Radiation therapy for squamous cell carcinoma of the supraglottic larynx.  Am J Clin Oncol. 1989;  12 17-23
    CrossrefPubMedGoogle Scholar
  • 205 Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. Carcinoma of the supraglottic larynx: a basis for comparing the results of radiotherapy and surgery.  Head Neck. 1990;  12 204-209
    CrossrefPubMedGoogle Scholar
  • 206 Inoue Ta, Matayoshi Y, Inoue To, Ikeda H, Teshima T, Murayama S. Prognostic factors in telecobalt therapy for early supraglottic carcinoma.  Cancer. 1993;  72 57-61
    CrossrefPubMedGoogle Scholar
  • 207 Mendenhall WM, Parsons JT, Mancuso AA, Stringer SP, Cassisi NJ. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery.  Head Neck. 1996;  18 24-35
    CrossrefPubMedGoogle Scholar
  • 208 Hafidh M, Tibbo J, Trites J, Corsten G, Hart RD, Nasser J, Wilke D, Taylor SM. Radiotherapy for T1 and T2 laryngeal cancer: the Dalhousie University Experience.  J Otolaryngol Head Neck Surg. 2009;  38 434-439
    PubMedGoogle Scholar
  • 209 Borgaert WVD, Ostyn F, Schueren EVD. The different clinical presentation, behavior and prognosis of carcinomas originating in the epilarynx and the lower supraglottis.  Radiother Oncol. 1983;  1 117-131
    CrossrefPubMedGoogle Scholar
  • 210 Mancuso AA, Mukherji SK, Schmalfuss I, Mendenhall W, Parsons J, Pameijer F, Hermans R, Kubilis P. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma.  J Clin Oncol. 1999;  17 631-637
    PubMedGoogle Scholar
  • 211 Johansen LV, Overgaard J, Hjelm-Hansen M, Gadeberg C. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985.  Int J Radiat Oncol Biol Phys. 1990;  18 1307-1313
    PubMedGoogle Scholar
  • 212 Johansen LV, Grau C, Overgaard J. Supraglottic carcinoma: Patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients.  Int J Radiat Oncol Biol Phys. 2002;  53 948-958
    CrossrefPubMedGoogle Scholar
  • 213 Beckhardt RN, Murray JG, Ford CN, Grossman JE, Brandenburg JH. Factors influencing outcome in supraglottic laryngectomy.  Head Neck. 1994;  16 232-239
    CrossrefPubMedGoogle Scholar
  • 214 Logemann JA, Gibbons P, Rademaker AW, Poulski BR, Kahrilas PJ, Bacon M, Bowman J, McCracken E. Mechanisms of recovery of swallow after supraglottic laryngectomy.  J Speech Hear Res. 1994;  37 965-974
    PubMedGoogle Scholar
  • 215 Roh JL, Kim DH, Park CI. Voice, swallowing and quality of life in patients after transoral laser surgery for supraglottic carcinomas.  J Surg Oncol. 2008;  98 184-189
    CrossrefPubMedGoogle Scholar
  • 216 Cabanillas R, Rodrigo JP, Llorente JL, Suarez C. Oncologic outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach.  Head Neck. 2008;  30 750-755
    CrossrefPubMedGoogle Scholar
  • 217 Rademaker AW, Logemann JA, Pauloski BR, Bowman JB, Lazarus CL, Sisson GA, Milianti FJ, Graner D, Cook BS, Collin SL. Recovery of postoperative swallowing in patients undergoing partial laryngectomy.  Head Neck. 1993;  15 325-334
    CrossrefPubMedGoogle Scholar
  • 218 Schweinfurth JM, Silver SM. Patterns of swallowing after supraglottic laryngectomy.  Laryngoscope. 2000;  110 1266-1270
    CrossrefPubMedGoogle Scholar
  • 219 Lewin JS, Hutcheson KA, Barringer DA, May AH, Roberts DB, Holsinger FC, Diaz EM. Functional analysis of swallowing outcomes after supracricoid partial laryngectomy.  Head Neck. 2008;  30 559-566
    CrossrefPubMedGoogle Scholar
  • 220 Hoffman HT, Karnell LH, Shah JP, Ariyan S, Brown GS, Fee WE, Glass AG, Goepfert H, Ossoff RH, Fremgen AM. Hypopharyngeal cancer patient care evaluation.  Laryngoscope. 1997;  107 1005-1017
    CrossrefPubMedGoogle Scholar
  • 221 Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The national cancer data base report on cancer of the head and neck.  Arch Otolaryngol Head and Neck Surg. 1998;  124 951-962
    PubMedGoogle Scholar
  • 222 Garden AS, Morrison WH, Clayman GL, Ang KK, Peters LJ. Early squamous cell carcinoma of the hypopharynx: outcomes of treatment with radiation alone to the primary disease.  Head Neck. 1996;  18 317-322
    CrossrefPubMedGoogle Scholar
  • 223 Wang CC. Carcinoma of the hypopharynx. In: Wang CC (Ed). Radiation Therapy for Head And Neck Neoplasms John Wiley & Sons, Inc, New York, Chichester, Brisbane, Toronto, Singapore, Weinheim; 1998: 205-220
    Google Scholar
  • 224 Nakamura K, Shioyama Y, Kawashima M, Saito Y, Nakamura N, Nakata K, Hareyama M, Takada T, Karasawa K, Watanabe T, Yorozu A, Tachibana H, Suzuki G, Hayabuchi N, Toba T, Yamada S. Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy.  Int J Radiat Oncol Biol Phys. 2006;  65 1045-1050
    CrossrefPubMedGoogle Scholar
  • 225 Yoshimura RI, Kagami Y, Ito Y, Asai M, Mayahara H, Sumi M, Itami J. Outcomes in patients with early-stage hypopharyngeal cancer treated with radiotherapy.  Int J Radiat Oncol Biol Phys. 2010;  77 1017-1023
    CrossrefPubMedGoogle Scholar
  • 226 Chevalier RJ, Watelet JB, Darras JA, Piquet JJ. Supraglottic hemilaryngopharyngectomy plus radiation for the treatment of early lateral margin and pyriform sinus carcinoma.  Head Neck. 1997;  19 1-5
    CrossrefPubMedGoogle Scholar
  • 227 Makeieff M, Mercante G, Jouzdani E, Garrel R, Crampette L, Guerrier B. Supraglottic hemilaryngopharyngectomy for the treatment of T1 and T2 carcinomas of laryngeal margin and piriform sinus.  Head Neck. 2004;  26 701-705
    CrossrefPubMedGoogle Scholar
  • 228 Laccourreye O, Merite-Drancy A, Brasnu D, Chabardes E, Cauchois R, Menard M, Lacourreye H. Supracricoid hemilaryngectomy in selected pyriform sinus carcinoma staged as T2.  Laryngoscope. 1993;  103 1379
    PubMedGoogle Scholar
  • 229 Laccourreye O, Ishoo E, De Mones E, Garcia D, Kania R, Hans S. Supracricoid hemilaryngopharyngectomy in patients with invasive squamous cell carcinoma of the pyriform sinus. Part I: Technique, complications, and long-term functional outcome.  Ann Otol Rhinol Laryngol. 2005;  114 25-34
    PubMedGoogle Scholar
  • 230 Steiner W, Ambrosch P, Hess CF, Kron M. Organ preservation by transoral laser microsurgery in piriform sinus carcinoma.  Otolaryngol Head Neck Surg. 2001;  124 58-67
    CrossrefPubMedGoogle Scholar
  • 231 Martin A, Jäckel MC, Christiansen H, Mahmoodzada M, Kron M, Steiner W. Organ preserving transoral laser microsurgery for cancer of the hypopharynx.  Laryngoscope. 2008;  118 398-402
    CrossrefPubMedGoogle Scholar
  • 232 Karatzanis AD, Psychogios G, Waldfahrer F, Zenk J, Hornung J, Velegrakis GA, Iro H. T1 and T2 Hypopharyngeal cancer treatment with laser microsurgery.  J Surg Oncol. 2010;  102 27-33
    CrossrefPubMedGoogle Scholar
  • 233 Johansen LV, Grau C, Overgaard J. Hypopharyngeal squamous cell carcinoma. Treatment results in 138 consecutively admitted patients.  Acta Oncol. 2000;  39 529-536
    CrossrefPubMedGoogle Scholar
  • 234 Niibe Y, Karasawa K, Mitsuhashi T, Tanaka Y. Hyperfractionated radiation therapy for hypopharyngeal carcinoma compared with conventional radiation therapy: local control, laryngeal preservation and overall survival.  Jpn J Clin Oncol. 2003;  33 450-455
    CrossrefPubMedGoogle Scholar
  • 235 Tombolini V, Santarelli M, Raffetto N, Donato V, Valeriani M, Ferretti A, Enrici RM. Radiotherapy in the treatment of stage III-IV hypopharyngeal carcinoma.  Anticancer Res. 2004;  24 349-354
    PubMedGoogle Scholar
  • 236 Lee MS, Ho HC, Hsiao SH, Hwang JH, Lee CC, Hung SK. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer.  Acta Otolaryngol. 2008;  28 103-109
    PubMedGoogle Scholar
  • 237 Lefebvre JL, Chevalier D, Luboinski B, Traissac L, Andry G. et al . Is laryngeal preservation with induction chemotherapy safe in the treatment of hypopharyngeal SCC? Final results of the phase III EORTC 24891 trial.  J Clin Oncol. 2004;  22 (suppl) 14
    PubMedGoogle Scholar
  • 238 Ogura JH, Jurema DA, Watson RK. Partial laryngopharyngectomy and neck dissection for pyriform sinus cancer.  Laryngoscope. 1960;  70 1399-1417
    PubMedGoogle Scholar
  • 239 Ogura JH, Marks JE, Freemann RB. Results of conservation surgery for cancers of the supraglottis and pyriform sinus.  Laryngoscope. 1980;  90 591-600
    PubMedGoogle Scholar
  • 240 Spector JG, Sessions DG, Emami B, Simpson J, Haughey B, Harvey J, Fredrickson JM. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results.  Laryngoscope. 1995;  105 397-406
    CrossrefPubMedGoogle Scholar
  • 241 Kraus DH, Zelefsky MJ, Brock HA, Huo J, Harrison LB, Shah JP. Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx.  Otolaryngol Head Neck Surg. 1997;  116 637-641
    CrossrefPubMedGoogle Scholar
  • 242 Czaja JM, Gluckman JL. Surgical management of early-stage hypopharyngeal carcinoma.  Ann Otol Rhinol Laryngol. 1997;  106 909-913
    PubMedGoogle Scholar
  • 243 Laccourreye H, Lacau St Guily J, Brasnu D, Fabre A, Menard M. Supracricoid hemilaryngopharyngectomy. Analysis of 240 cases.  Ann Otol Rhinol Laryngol. 1987;  96 217-221
    PubMedGoogle Scholar
  • 244 Foucher M, Poissonnet G, Rame JP, Toussaint B, Vedrine PO, Dassonville O, de Raucourt D, Cosmidis A. T1-T2 N0 hypopharyngeal cancers treated with surgery alone. A GETTEC study.  Ann Otolaryngol Chir Cervicofac. 2009;  126 203-207
    CrossrefPubMedGoogle Scholar
  • 245 Kania R, Hans S, Garcia D, Brasnu D, De Mones E, Laccourreye O. Supracricoid hemilaryngopharyngectomy in patients with invasive squamous cell carcinoma of the pyriform sinus. Part II: Incidence and consequences of local recurrence.  Ann Otol Rhinol Laryngol. 2005;  114 95-104
    PubMedGoogle Scholar
  • 246 Steiner W, Herbst M. Combined therapy of hypopharyngeal carcinoma consisting of endoscopic laser surgery and postoperative radiotherapy. In: Sauer R, Schwab W. (Eds.).Combined therapy of oropharyngeal and hypopharyngeal carcinoma Urban & Schwarzenberg, München, Wien, Baltimore; 1987: 108-113
    Google Scholar
  • 247 Steiner W. Therapie des Hypopharynxkarzinoms.  HNO. 1994;  42 4-13 , 84–88, 104–112, 147–156, 157–165
    PubMedGoogle Scholar
  • 248 Steiner W. Therapy of hypopharyngeal carcinoma. In: Johnson JT, Didolkar MS (Eds). Head and Neck Cancer Vol III. Proceedings of the Third International Conference on Head and Neck Cancer, San Francisco, 26-30 July 1992. Excerpta Medica Amsterdam, London, New York, Tokyo; 1993: 101-109
    Google Scholar
  • 249 Steiner W, Ambrosch P. CO2 laser microsurgery for hypopharyngeal carcinoma. In: Smee R, Bridger GP (Eds).Laryngeal Cancer Proceedings of the 2nd World Congress on Laryngeal Cancer, Sydney, 20–24 February 1994. Elsevier, Amsterdam, Lausanne, New York, Oxford, Shannon, Tokyo; 1994: 606-609
    Google Scholar
  • 250 Steiner W, Ambrosch P, Uhlig P. et al . CO2 laser microsurgery for hypopharyngeal carcinoma. Proceedings of the 3rd European Congress of the European Federation of Oto-Rhino-Laryngological Societies “EUFOS”, Budapest, 9–14 June 1996.  Monduzzi Editore S.p.a. Bologna. 1996;  669-672
    PubMedGoogle Scholar
  • 251 Rudert HH. The CO2 laser in the management of hypopharyngeal cancer.  Current Opinion in Otolaryngology & Head and Neck Surgery. 2002;  10 118-122
    CrossrefPubMedGoogle Scholar
  • 252 Vilaseca I, Blanch JL, Bernal-Sprekelsen M, Moragas M. CO2 laser surgery: a larynx preservation alternative for selected hypopharyngeal carcinomas.  Head Neck. 2004;  26 953-959
    CrossrefPubMedGoogle Scholar
  • 253 Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Manuso AA. Parameters that predict local control following definitive radiotherapy for squamous cell carcinoma of the head and neck.  Head Neck. 2003;  25 535-542
    CrossrefPubMedGoogle Scholar
  • 254 Dirven R, Swinson BD, Gao K, Clark JR. The assessment of pharyngocutaneous fistula rate in patients treated primarily with definitive radiotherapy followed by salvage surgery of the larynx and hypopharynx.  Laryngoscope. 2009;  119 1691-1695
    CrossrefPubMedGoogle Scholar
  • 255 Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Mukherji SK, Hermans R, Kubilis PS. Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy.  Head Neck. 1998;  20 159-169
    CrossrefPubMedGoogle Scholar
  • 256 Amdur RJ, Mendenhall WM, Stringer SP, Villaret DB, Cassisi NJ. Organ preservation with radiotherapy for T1-T2 carcinoma of the pyriform sinus.  Head Neck. 2001;  23 353-362
    CrossrefPubMedGoogle Scholar
  • 257 Jones AS. Tumours of the hypopharynx. In: Jones AS, Philipps DE, Hilgers FJ (Eds.). Diseases of the Head and Neck, Nose and Throat Oxford University Press, Inc, New York; 1998: 230-249
    Google Scholar
  • 258 Rabbani A, Amdur RJ, Mancuso AA, Werning JW, Kirwan J, Morris CG, Mendenhall WM. Definitive radiotherapy for T1-T2 squamous cell carcinoma of pyriform sinus.  Int J Radiat Oncol Biol Phys. 2008;  72 351-355
    CrossrefPubMedGoogle Scholar
  • 259 Taylor SG, Murthy AK, Griem KL, Recine DC, Kiel K, Blendowski C, Hurst PB, Showel JT, Hutchinson Jr JC, Campanella RS, Chen S, Caldarelli DD. Concomitant cisplatin/5-FU infusion and radiotherapy in advanced head and neck cancer. 8-year analysis of results.  Head Neck. 1997;  19 684-691
    CrossrefPubMedGoogle Scholar
  • 260 Khan A, Spiro JD, Dowsett R, Greenberg BR. Sequential chemotherapy and radiotherapy for organ preservation in advanced resectable nonlaryngeal head and neck cancer.  Am J Clin Oncol. 1999;  22 403-407
    CrossrefPubMedGoogle Scholar
  • 261 Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data.  Lancet. 2000;  355 949-955
    CrossrefPubMedGoogle Scholar
  • 262 Prades JM, Schmitt TM, Timoshenko AP, Simon PG, de Cornulier J, Durand M, Guillot A, Martin C. Concomitant chemoradiotherapy in pyriform sinus carcinoma.  Arch Otolaryngol Head Neck Surg. 2002;  128 384-388
    PubMedGoogle Scholar
  • 263 Wahlberg PCG, Andersson KEH, Biörklund AT. et al . Carcinoma of the hypopharynx: analysis of incidence and survival in Sweden over a 30-year period.  Head Neck. 1998;  20 714-719
    CrossrefPubMedGoogle Scholar
  • 264 Bahadur S, Thakar A, Mohanti BK, Lal P. Results of radiotherapy with, or without, salvage surgery versus combined surgery and radiotherapy in advanced carcinoma of the hypopharynx.  J Laryngol Otol. 2002;  116 29-32
    PubMedGoogle Scholar
  • 265 Godballe C, Jorgensen K, Hansen O, Bastholt L. Hypopharyngeal cancer: results of treatment based on radiation therapy and salvage surgery.  Laryngoscope. 2002;  112 834-838
    CrossrefPubMedGoogle Scholar
  • 266 Chen SW, Tsai MH, Yang SN, Liang JA, Shiau AC, Lin FJ. Treatment results of hypopharyngeal cancer based on definitive radiotherapy: who is suitable for laryngeal preservation?.  J Laryngol Otol. 2008;  122 506-512
    PubMedGoogle Scholar
  • 267 Lazarus CL, Logemann JA, Pauloski BR, Colangelo LA, Kahrilas PJ, Mittal BB, Pierce M. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy.  Laryngoscope. 1996;  106 1157-1166
    CrossrefPubMedGoogle Scholar
  • 268 Kotz T, Abraham S, Beitler J, Wadler S, Smith RV. Pharyngeal transport dysfunction consequent to an organ-sparing protocol.  Arch Otolaryngol Head Neck Surg. 1999;  125 410-413
    PubMedGoogle Scholar
  • 269 Lazarus C, Logemann JA, Shi G, Kahrilas P, Pelzer H, Kleinjan K. Does laryngectomy improve swallowing after chemoradiotherapy?.  A case study. Arch Otolaryngol Head Neck Surg. 2002;  128 54-57
    PubMedGoogle Scholar
  • 270 Lee WT, Akst LM, Adelstein DJ, Saxton JP, Wood BG, Strome M, Butler RS, Esclamado RM. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation.  Head Neck. 2006;  28 808-812
    CrossrefPubMedGoogle Scholar
  • 271 Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. Radiotherapy alone or combined with neck dissection for T1-T2 carcinoma of the pyriform sinus: an alternative to conservation surgery.  Int J Radiat Oncol Biol Phys. 1993;  27 1017-1027
    CrossrefPubMedGoogle Scholar
  • 272 Rodriguez J, Point D, Brunin F, Jaulerry C, Brugère J. Surgery of the hypopharynx after radiotherapy.  Bull Cancer Radiother. 1996;  83 17-23
    PubMedGoogle Scholar
  • 273 Davidson J, Keane T, Brown D, Freeman J, Gullane P, Irish J, Rotstein L, Pintilie M, Cummings B. Surgical salvage after radiotherapy for advanced laryngopharyngeal carcinoma.  Arch Otolaryngol Head Neck Surg. 1997;  123 420-424
    CrossrefPubMedGoogle Scholar
  • 274 Clark JR, Gilbert R, Irish J, Brown D, Neligan P, Gullane P. Morbidity after flap reconstruction of hypopharyngeal defects.  Laryngoscope. 2006;  116 173-181
    CrossrefPubMedGoogle Scholar
  • 275 Taki S, Homma A, Oridate N, Suzuki S, Suzuki F, Sakashita T, Fukuda S. Salvage surgery for local recurrence after chemoradiotherapy or radiotherapy in hypopharyngeal cancer patients.  Eur Arch Otorhinolaryngol. 2010;  267 1765-1769
    CrossrefPubMedGoogle Scholar
  • 276 Harari PM. Why has induction chemotherapy for advanced head and neck cancer become a united states community standard of practice?.  J Clin Oncol. 1997;  15 2050-2055
    PubMedGoogle Scholar
  • 277 Lewin F, Damber L, Jonsson H, Andersson T, Berthelsen A, Biörklund A, Blomqvist E, Evensen JF, Hansen HS, Hansen O, Jetlund O, Mercke C, Modig H, Overgaard M, Rosengren B, Tausjö J, Ringborg U. Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized phase III study.  Radiother Oncol. 1997;  43 23-28
    CrossrefPubMedGoogle Scholar
  • 278 Wolf GT, Forastiere A, Ang K, Brockstein B, Conley B, Goepfert H, Kraus D, Lefebvre JL, Pajak TF, Pfister D, Urba S. Workshop report: Organ preservation strategies in advanced head and neck cancer: current status and future directions.  Head Neck. 1999;  21 689-1017
    CrossrefPubMedGoogle Scholar
  • 279 Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer Phase III Trial.  J Natl Cancer Inst. 1996;  88 890-899
    CrossrefPubMedGoogle Scholar
  • 280 Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois L, Hupperets P, Barzan L, de Raucourt D, Chevalier D, Licitra L, Lunghi F, Stupp R, Lacombe D, Bogaerts J, Horiot JC, Bernier J, Vermorken JB. Phase 3 randomized trial on larynx preservation comparing sequential vs. alternating chemotherapy and radiotherapy.  J Natl Cancer Inst. 2009;  101 142-152
    CrossrefPubMedGoogle Scholar
  • 281 Urba SG, Wolf GT, Bradford CR, Thornton AF, Eisbruch A, Terrell JE, Carpenter V, Miller T, Tang G, Strawderman M. Neoadjuvant therapy for organ preservation in head and neck cancer.  Laryngoscope. 2000;  110 2074-2080
    CrossrefPubMedGoogle Scholar
  • 282 Dietz A, Rudat V, Dreyhaupt J, Pritsch M, Hoppe F, Hagen R, Pfreundner L, Schröder U, Eckel H, Hess M, Schröder M, Schneider P, Jens B, Zenner HP, Werner JA, Engenhardt-Cabillic R, Vanselow B, Plinkert P, Niewald M, Kuhnt T, Budach W, Flentje M. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial).  Eur Arch Otorhinolaryngol. 2009;  266 1291-1300
    CrossrefPubMedGoogle Scholar

Korrespondenzadresse

Prof. Dr. med. Petra Ambrosch

Klinik für Hals-, Nasen-,

Ohrenheilkunde

Kopf- und Halschirurgie

der Christian-Albrechts-

Universität zu Kiel

Arnold-Heller-Straße 14

24105 Kiel

Email: ambrosch@hno.uni-kiel.de